BBS:      TELESC.NET.BR
Assunto:  Palantir's 'unlimited access' to patient data
De:       Mike Powell
Data:     Sat, 30 May 2026 08:22:22 -0500
-----------------------------------------------------------
Palantir's 'unlimited access' to patient data  we examine the US tech giant's 
controversial 330 million contract with the NHS

Date:
Fri, 29 May 2026 15:39:02 +0000

Description:
While the NHS has just granted Palantir "unlimited access" to patient data, 
the relationship between the UK public health sector and the controversial 
American firm dates back to 2020. Here's how we get here, and what's at stake.

FULL STORY
Who would have thought that the
secretive American spytech and data analyst firm, Palantir Technologies, 
could have gotten so embedded in the UKs government and public sector? 

At first under the radar, Palatnirs 330 million contract with the NHS is the 
deal thats recently caused the headlines. The news that the NHS has granted 
Palantir " unlimited access " to identifiable patient health data has come at 
a moment when the backlash against the American analyst giant has never been 
stronger.

Two petitions urging the UK government to scrap its contracts with Palantir 
have already attracted over 200,000 signatures, according to The Guardian , 
and the UK government is reportedly now considering activating a break clause 
to end the deal with the NHS by early 2027. 

Privacy campaigners and NHS staff alike have expressed deep concerns over how 
this data-sharing agreement could compromise patient confidentiality. 

But is the Palantir-NHS partnership really as dangerous as critics claim? 
And, more importantly, what steps can UK citizens take to prevent their 
personal medical data from being sucked up by todays most controversial 
company on the planet? What is Palantir and how does the NHS use its 
software? Headquartered in Miami, Palantir Technologies is a data analytics 
firm specialising in AI-powered tools designed to manage large datasets. 

Co-founded in 2003 by PayPal's creator, Peter Thiel, among others, Palantir 
began its journey with deep ties to the US intelligence, and was initially 
funded by the CIA's venture capital body, In-Q-Tel . 

Palantirs flagship software platforms, Gotham and Foundry , are widely used 
by government organizations and businesses globally to uncover data patterns 
and support decision-making operations. 

These tools are currently deployed across various public sectors, including 
healthcare, policing, border enforcement, intelligence agencies, and defense. 
Palantir first established ties with the UK's public health sector in 2020, 
when Boris Johnson's government began using Foundry , alongside tools from 
Microsoft, Google, and Amazon, to manage the Covid-19 pandemic. 

That relationship deepened in 2023 when then-Prime Minister Rishi Sunak 
signed the 330 million contract with the American firm. The deal tasked 
Palantir with leading a corporate consortium including Accenture, PwC, NECS, 
and Carnall Farrar  to build the NHS's new Federated Data Platform (FDP). 

A recent Financial Times 
disclosure has begun to cause concern, however, after it brought to light an 
internal NHS briefing note which explicitly earmarked "unlimited access" to 
identifiable patient data for certain contractor admin roles. 

And, while the UK government claims to have already seen significant 
improvements in its data management flow, thanks to Palantir's Federated Data 
Platform (FDP), a report by Democracy for Sale says that staff have found 
Palantir's newly built platform to be 10 times slower than the existing 
system, citing an internal NHS document. 

Palantir has strongly rejected these allegations, however. In a statement to 
Democracy for Sale, the US firm argued that "comparing the two systems is not 
like-for-like," adding that its platform "introduces guardrails to improve 
data correctness, enforce purpose-based access and allow more controlled data 
sharing".

What does it mean for your privacy? Under the terms of the contract 
with the NHS , Palantir is named strictly as a "data processor". This means 
it cannot decide how the information that its software processes is used. In 
other words, Palantir could face direct liability should it fail to secure 
this data or violate NHS instructions. 

Indeed, a Palantir spokesperson told the Financial Times that using this data 
for any other purpose would be "not only illegal but technically impossible 
due to granular access controls overseen by the NHS". 

That said, the exact details of how Palantir can use UK citizens health data 
remain obscured. As The Conversation noted , the publicly available version 
of the contract was published with "nearly all the data protection text" 
heavily redacted. 

However, in an open letter published earlier this month , a coalition of 
critical NHS personnel argued that current data privacy protections within 
the FDP system may be "inadequate", raising concerns about Palantir's access 
to FDP data and its use of artificial intelligence. 

The signatories also highlight potential conflicts that could arise from the 
company's obligations under sweeping US surveillance legislation like the 
CLOUD Act and the Foreign Intelligence Surveillance Act (FISA), which could 
allow the US government to request data held on the systems of an American 
corporation, they note.  Critics have also raised
concerns over how sensitive health data could be misused across different 
government bodies, such as immigration. The coalition wrote in the open 
letter: 

"We are alarmed that Palantir UK CEO Louis Mosley confirmed to the Observer 
that Palantir would share NHS data for immigration enforcement purposes 
should a future government legislate for it." 

The NHS is just one of the UK public sectors where Palantir currently 
operates. An investigation by The Nerve last January found details of 34 
active contracts across at least 10 government departments, as well as local 
councils and police authorities. 

 Speaking to the BBC , Mosley welcomed the scrutiny and insisted that his 
company has "no interest" in UK patient data. 

"Its not the legal basis on which we operate, in the same way that Microsoft 
Excel or Microsoft Word or email is used in the NHS, and again that is NHS 
data, Microsoft doesnt have access to it, nor do we to NHS data," he said. 

Looking at the companys track record, however, there is a demonstrable risk 
that NHS patient health data could one day be repurposed. 

For example, January revelations from 404media suggest that US citizen health 
data is fed to a Palantir-developed app called ELITE, which is used by 
Immigration and Customs Enforcement (ICE) agents to map and target suspected 
illegal immigrants. 

This cross-pollination of healthcare data and immigration enforcement is 
exactly what critics of Palantirs involvement with the NHS fear the most. 

Why is Palantir so controversial?

Palantir co-founder Peter Thiel is well-known for his polarizing views.
As reported by The Guardian in 2023, Thiel previously stated that the "NHS 
makes people sick" and described the British public's affection for the 
health service as a case of "Stockholm syndrome". 

In a 22-point manifesto published in April , Palantir CEO Alex Karp expanded 
on the moral duty of tech companies in defense and AI warfare, 
controversially asserting that "some cultures have produced vital advances; 
others remain dysfunctional and regressive". 

This sparked a backlash within the digital rights community, prompting NymVPN 
CEO Harry Halpin to publish his own "anti-Palantir" manifesto outlining the 
necessity to fight the company's vision . 

However, the opposition to Palantir extends far beyond philosophical 
disagreements. 

For over a decade, Palantir has been the backbone behind ICE s controversial 
tracking and deportation operations, and, more recently, a deal with the 
Israeli military has also become a source of public concern. Is there 
something we can do about it? While it is difficult to predict whether the UK 
government will activate the break clause in Palantir's contract, there are 
steps citizen can take if they wish to restrict access to their health data  
though they do come with significant caveats. 

Patients can opt out of sharing their health records, which prevents GP 
practices, hospitals, and other providers from distributing their data more 
broadly. 

However, you cannot currently opt out specifically from "products used in the 
NHS Federated Data Platform". 

Crucially, a mass opt-out of health data sharing would severely impact the 
efficacy of these datasets, undermining the overall quality of medical 
research and public health planning. 

Beyond immediate privacy risks, this erosion of data quality is exactly what 
NHS employees fear most. A 2023 YouGov poll found that nearly half of UK 
adults would likely opt out of data sharing if a private company like 
Palantir began processing their personal information. 

Whether this potential erosion of trust between UK patients and the health 
service will prompt a U-turn in the Palantir-NHS collaboration remains to be 
seen. What is certain, however, is that the intense debate surrounding the 
future of UK health data privacy is far from over. 

We have contacted Palantir and the NHS for comment and will update this 
article if we receive a response.

Link to news story:
https://www.techradar.com/vpn/vpn-privacy-security/palantirs-unlimited-access-
to-patient-data-we-examine-the-us-tech-giants-controversial-gbp330-million-con
tract-with-the-nhs

$$
--- MultiMail/DOS
 * Origin: Capitol City Hub (1:2320/105)

-----------------------------------------------------------
[Voltar]